SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-22-000058
Filing Date
2022-08-15
Accepted
2022-08-15 17:46:57
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20220630.htm   iXBRL 10-Q 1796001
2 EX-10.3 ex103_exicure-formofrsuagr.htm EX-10.3 57399
3 EX-31.1 exicureexhibit311-63022.htm EX-31.1 8022
4 EX-31.2 exicureexhibit312-63022.htm EX-31.2 7966
5 EX-32.1 exicureexhibit321-63022.htm EX-32.1 8304
11 xcur-20220630_g1.jpg GRAPHIC 29733
  Complete submission text file 0001698530-22-000058.txt   7292354

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220630.xsd EX-101.SCH 46247
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20220630_cal.xml EX-101.CAL 65442
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20220630_def.xml EX-101.DEF 195360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220630_lab.xml EX-101.LAB 597421
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220630_pre.xml EX-101.PRE 389066
76 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220630_htm.xml XML 1053265
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 221167123
SIC: 2834 Pharmaceutical Preparations